These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24023507)

  • 21. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
    Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
    Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis.
    Taghinezhad-S S; Keyvani H; Bermúdez-Humarán LG; Donders GGG; Fu X; Mohseni AH
    Cell Mol Life Sci; 2021 Feb; 78(4):1191-1206. PubMed ID: 32979054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
    Yang W; Song Y; Lu YL; Sun JZ; Wang HW
    Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies prevalence against HPV-6b and -16 recombinant fusion proteins in Korean patients with cervical neoplasia.
    Park SN; Yoon HS; Choi YK; Choe IS; Chung RP; Chee YH; Namkoong SE; Kim SJ; Park JS
    J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):609-17. PubMed ID: 8640473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic vaccine: is it feasible?
    Gissmann L; Nieto K
    Arch Med Res; 2009 Aug; 40(6):493-8. PubMed ID: 19853190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
    Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
    Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "I thought cancer was one of those random things. I didn't know cancer could be caught...": adolescent girls' understandings and experiences of the HPV programme in the UK.
    Hilton S; Smith E
    Vaccine; 2011 Jun; 29(26):4409-15. PubMed ID: 21514348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
    Zhao Z; Wang L; Ma B
    Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
    Van den Bergh JM; Guerti K; Willemen Y; Lion E; Cools N; Goossens H; Vorsters A; Van Tendeloo VF; Anguille S; Van Damme P; Smits EL
    J Cell Mol Med; 2014 Jul; 18(7):1372-80. PubMed ID: 24979331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV vaccination and cervical cancer.
    Szarewski A
    Curr Oncol Rep; 2012 Dec; 14(6):559-67. PubMed ID: 22890794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
    Bontkes HJ; de Gruijl TD; van den Muysenberg AJ; Verheijen RH; Stukart MJ; Meijer CJ; Scheper RJ; Stacey SN; Duggan-Keen MF; Stern PL; Man S; Borysiewicz LK; Walboomers JM
    Int J Cancer; 2000 Oct; 88(1):92-8. PubMed ID: 10962445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Papillomavirus infections and cervical tumorigenesis].
    Kiyono T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
    Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
    Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
    Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylactic and therapeutic vaccination against human papillomavirus].
    Brun JL; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge and Attitudes of Medical and Non-Medical Turkish University Students about Cervical Cancer and HPV Vaccination.
    Borlu A; Gunay O; Balci E; Sagiroglu M
    Asian Pac J Cancer Prev; 2016; 17(1):299-303. PubMed ID: 26838228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.